No difference in treatment outcome between patients with nodal versus extranodal diffuse large B-cell lymphoma

BACKGROUND AND AIM: Diffuse large B-cell lymphoma (DLBCL) has been classified using various parameters, including the site of origin. Studies have reported conflicting outcomes when DLBLC patients were stratified according to the site of origin. This study aimed to investigate the response rate and...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Saqib Raza, Muhammad, Afzal, Soomar, Salman Muhammad, Shoaib, Daania, Arshad Ali, Ayesha, Muhammad, Tariq, Zahir, Muhammad Nauman, Abdul Jabbar, Adnan, Abdul Rashid, Yasmin, Heger, Michal, Moosajee, Munira Shabbir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Whioce Publishing Pte. Ltd. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844226/
https://www.ncbi.nlm.nih.gov/pubmed/36687299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844226/
https://www.ncbi.nlm.nih.gov/pubmed/36687299

Ejemplares similares